^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
MTV273
i
Other names: autologous T cells expressing BCMA-specific chimeric antigen receptors, MTV273, CART-BCMA, Autologous T cells engineered to contain an anti-BCMA scFv coupled to TCRζ And 4-1BB signaling domains, Autologous T cells expressing BCMA-specific chimeric antigen receptors with tandem TCR and 4-1BB costimulatory domains
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Novartis, University of Pennsylvania
Drug class:
BCMA-targeted CAR-T immunotherapy
Related drugs:
